NASDAQ:CPRX
Catalyst Pharmaceuticals Stock News
$15.06
-0.270 (-1.76%)
At Close: Jun 14, 2024
Why Is Catalyst (CPRX) Up 0.7% Since Last Earnings Report?
12:36pm, Friday, 07'th Jun 2024
Catalyst (CPRX) reported earnings 30 days ago. What's next for the stock?
Catalyst Pharmaceuticals Receives U.S. FDA Approval For Increased Maximum Daily Dose For FIRDAPSE®
01:41pm, Thursday, 30'th May 2024
CORAL GABLES, Fla., May 30, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, dev
Catalyst Pharmaceuticals to Participate at the Jefferies Global Healthcare Conference 2024
08:03am, Tuesday, 28'th May 2024
CORAL GABLES, Fla., May 28, 2024 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, dev
2 Incredible Growth Stocks to Buy Hand Over Fist Right Now
08:00am, Wednesday, 15'th May 2024
Growth stocks have been steadily marching higher since the 2008 financial crisis. Even so, there are still plenty of compelling bargains in the space.
Catalyst's New CEO Has Big Ideas For The Small Biotech
09:30am, Friday, 10'th May 2024
Richard Daly has watched Catalyst Pharmaceuticals transform. Now, as the company's new CEO, he has some metamorphic ideas of his own.
Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues
12:41pm, Thursday, 09'th May 2024
Catalyst (CPRX) reports first-quarter results, wherein earnings and revenues beat the Zacks Consensus Estimate, driven by strong Firdapse sales.
Catalyst Pharmaceuticals, Inc. (CPRX) Q1 2024 Earnings Call Transcript
10:52am, Thursday, 09'th May 2024
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX ) Q1 2024 Earnings Conference Call May 9, 2024 8:30 AM ET Company Participants Michael Kalb - Chief Financial Officer Richard Daly - President and Chief Exe
Top 10% Biotech Stock Catalyst Pharma Doubles Wall Street's Profit Views
05:08pm, Wednesday, 08'th May 2024
Catalyst Pharmaceuticals doubled Wall Street's earnings expectations late Wednesday, and the biotech stock recovered from an earlier slide.
Catalyst Pharmaceuticals Reports Solid First Quarter 2024 Financial Results and Provides Business Update
04:16pm, Wednesday, 08'th May 2024
Achieved Total Q1 2024 Revenues of $98.5 Million, a 15.4% YoY Increase, Underscored by Exceptional Execution and Continued Demand for Commercial Products
Catalyst Pharmaceutical (CPRX) Reports Next Week: Wall Street Expects Earnings Growth
11:07am, Wednesday, 01'st May 2024
Catalyst (CPRX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May
01:00am, Thursday, 25'th Apr 2024
Ad hoc announcement pursuant to Art. 53 LR A conference call will be held on April 25, 2024, at 14:30 CEST / 13:30 BST / 08:30 EDT.
Dirt-Cheap Delights: 3 Discounted Stocks That Could Triple by 2026
01:45pm, Wednesday, 24'th Apr 2024
Investing in discounted stocks for big gains is a time-tested strategy. Although short-term market fluctuations may capture the attention of many, companies with sustainable growth prospects often pro
Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024
08:00am, Monday, 22'nd Apr 2024
The Company will Host a Conference Call and Webcast on Thursday, May 9, 2024, at 8:30 AM ET The Company will Host a Conference Call and Webcast on Thursday, May 9, 2024, at 8:30 AM ET
Jim Cramer lays out his top small-cap healthcare picks
08:29pm, Friday, 05'th Apr 2024
'Mad Money' host Jim Cramer shares his small-cap healthcare stock picks.
Jim Cramer recommends five small-cap health-care stocks
06:51pm, Friday, 05'th Apr 2024
CNBC's Jim Cramer said he thinks it could be a good year for small cap stocks and shared his top picks.